24
Participants
Start Date
July 1, 2025
Primary Completion Date
October 1, 2026
Study Completion Date
December 1, 2026
Metformin
Metformin will be prescribed, reaching 1000mg/day (a standard dose). This will be done under the principal investigator's care and the patient's clinical team, including assessment of metformin adherence. Metformin will be prescribed for 6 months. Antipsychotic treatment will continue as per standard of care (metformin as adjunct therapy), as well as routine follow up.
Dalhousie University
OTHER
Nova Scotia Health Authority
OTHER